Trials / Completed
CompletedNCT02514499
Multiplex Testing for Evaluation of Breast Cancer Risk, Longitudinal Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 350 (planned)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The overall goal of the proposed research is to evaluate the uptake of testing and longitudinal risks and benefits of multiplex testing for cancer susceptibility in BRCA1/2 negative patients. This model will inform the selection of the outcomes and potential mediators and moderators of these outcomes, to inform the debate over utility, risks, and benefits of clinical incorporation of multiplex testing for breast cancer susceptibility.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Questionnaires |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2018-10-01
- Completion
- 2018-10-01
- First posted
- 2015-08-03
- Last updated
- 2019-07-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02514499. Inclusion in this directory is not an endorsement.